Thrombolytic therapy. State of the art.


Thrombolytic agents have become the corner stone in the treatment of acute myocardial infarction. However, the current agents are far from perfect. New thrombolytic drugs have been designed to overcome these shortcomings. Development of these agents has focused not only on increasing plasma half-life and thus allowing single-bolus administration, but also… (More)


Cite this paper

@article{Sinnaeve2001ThrombolyticTS, title={Thrombolytic therapy. State of the art.}, author={Peter R. Sinnaeve and Frans J J Van De Werf}, journal={Thrombosis research}, year={2001}, volume={103 Suppl 1}, pages={S71-9} }